ODD in EU: 10 years exclusivity
Posted: Wed Mar 16, 2016 1:31 pm
From Geron 10-K:
'In addition, ten years of market exclusivity is granted following drug product approval, meaning that another application for marketing authorization of a later similar medicinal product for the same therapeutic indication will generally not be approved in the EU.'
'In addition, ten years of market exclusivity is granted following drug product approval, meaning that another application for marketing authorization of a later similar medicinal product for the same therapeutic indication will generally not be approved in the EU.'